Lonza Group Ag (OTCMKTS:LZAGY) was upgraded by equities researchers at Jefferies Group LLC from a “hold” rating to a “buy” rating in a research note issued on Wednesday, July 19th, Marketbeat Ratings reports.

Shares of Lonza Group Ag (LZAGY) opened at 23.03 on Wednesday. The firm has a market cap of $14.12 billion, a PE ratio of 37.47 and a beta of 1.05. Lonza Group Ag has a 12-month low of $15.27 and a 12-month high of $24.31. The company has a 50 day moving average price of $22.72 and a 200 day moving average price of $20.21.

COPYRIGHT VIOLATION NOTICE: “Lonza Group Ag (LZAGY) Upgraded by Jefferies Group LLC to “Buy”” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/08/15/lonza-group-ag-lzagy-upgraded-to-buy-by-jefferies-group-llc-updated-updated-updated.html.

Lonza Group Ag Company Profile

Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech segment develops and manufactures active pharmaceutical ingredients for life-saving medicines; manufactures commercial bulk drug substance of monoclonal antibodies and recombinant proteins from mammalian cell cultures; and chemical contract manufacturing services, such as microbials, peptides, and small molecules.

Receive News & Stock Ratings for Lonza Group Ag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group Ag and related stocks with our FREE daily email newsletter.